Clover Health Reports 56% Revenue Growth to $743.2 Million in Q2 2026

Clover Health Investments, Corp. reported significant financial growth in its latest quarterly filing, with total revenues reaching $743.2 million for the three months ended June 30, 2026, a 56% increase from $477.6 million in the same period last year. For the first half of 2026, revenues surged 59% to $1.49 billion compared to $940 million in the prior year. The company achieved a net income of $28 million for the second quarter, reversing a loss of $10.6 million in the same quarter of 2025. This positive shift in profitability is attributed to a substantial increase in Medicare Advantage membership and higher per-member premiums.

Clover Health's operational metrics also reflect robust growth, with average membership increasing approximately 49% year-over-year to 157,309 members by the end of June 2026. The company reported a 57% rise in premiums earned, net, driven by both membership growth and an increase in per-member premiums, which were bolstered by improved star ratings from the Centers for Medicare & Medicaid Services (CMS). The company's PPO plans, which constitute the majority of its offerings, were rated at 4.0 stars, up from 3.5 stars in the previous year, contributing to higher premium rates.

In terms of expenses, Clover Health's net medical claims incurred rose by 56% to $590.2 million in the second quarter, reflecting the increased membership and higher per-member medical costs. However, the company managed to reduce salaries and benefits expenses by 12% to $54.1 million, primarily due to lower stock-based compensation. General and administrative expenses increased by 45% to $70.3 million, driven by the need to support the growing membership base.

Strategically, Clover Health has expanded its technology offerings with the launch of Counterpart Health, Inc., a new subsidiary aimed at providing its Clover Assistant technology to external payors and providers. This initiative is expected to enhance patient outcomes and reduce healthcare costs, thereby creating new growth opportunities for the company. Clover Health continues to maintain a strong liquidity position, with cash, cash equivalents, and investments totaling $443 million as of June 30, 2026.

Looking ahead, Clover Health anticipates continued growth in membership and revenue, supported by its strategic initiatives and improved star ratings. The company remains focused on leveraging its technology to enhance care delivery and operational efficiency, while also navigating the competitive landscape of the healthcare industry.